Luvo Health review

Luvo Health publishes the whole price list, which is rarer in this market than it sounds. Its pricing page carries a static table for every program it sells, with no quiz and no intake gate in front of it: compounded semaglutide injection is $249 for four weeks, the tablet route is $279, and compounded tirzepatide injection is $339. Read on August 28, 2026, those were the same entry prices we recorded on August 4 — the numbers have not moved in a month.

The thing to understand about Luvo is that four weeks is its most expensive way to buy. The page says so plainly — "Save more with longer commitments — no hidden fees" — and then actually shows the ladder: 4, 12, 24 and 52 weeks, each with its own total and its own per-week rate. Semaglutide injection runs about $62 a week on the four-week term and about $45 a week on the annual one. Tirzepatide runs about $85 a week on four weeks and about $67 on the year.

That lower number is a real saving, and it costs a real commitment. The 52-week semaglutide injection term is $2,327 and the tirzepatide term is $3,497, and each is a single charge up front rather than a subscription anyone can stop after a cycle. Anybody comparing Luvo's $45 a week against another company's monthly rate is comparing a year paid in advance against a month, which is not the same purchase. The four-week price is the honest figure to hold next to a month-to-month competitor.

There is a genuine brand-name route on the same list, priced without euphemism: Ozempic at $1,299 for four weeks, which is about $325 a week and roughly five times the compounded semaglutide rate beside it. Most companies selling compounded GLP-1s either do not offer the approved product at all or bury what it costs. Publishing it on the same table, at a price that plainly favors the compounded option, is the kind of disclosure that makes the rest of the page easier to trust.

Luvo also sells a microdosing line — semaglutide injection, semaglutide tablets and tirzepatide injection each at $179 for four weeks — alongside testosterone, hormone replacement, skincare and a longevity range that includes NAD+ and Sermorelin at $199. That breadth is worth knowing before you shop by price: the cheapest weight-loss figure on the page is a microdose, not a lower price for the same dose, and the $35 and $99 lines belong to entirely different products.

Two things Luvo does not publish. It names no compounding pharmacy, describing only "FDA-registered pharmacy partners" — so the company that actually makes the drug is not something a reader can check before buying. And it does not disclose which states it serves, which for a telehealth prescriber is a question you want answered before you pay for a year. Its compounded medications, here as everywhere, are not FDA-approved products.